2 results
Approved WMOCompleted
To evaluate the safety, tolerability and pharmacokinetics of ascending single and multiple doses of CH-4051.
Approved WMOCompleted
Primary objective: to confirm the efficacy of insulin degludec administered once daily plus mealtime insulin aspart in controlling glycaemia with respect to change from baseline in HbA1c after 26 weeks of treatment. Secundary objective: to compare…